Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-669899f699-vbsjw Total loading time: 0 Render date: 2025-05-03T18:14:51.622Z Has data issue: false hasContentIssue false

Chapter 12 - Autonomic Dysfunction and Failure in Parkinson’s Disease

Published online by Cambridge University Press:  05 March 2022

By
Thomas Foki ,
Birgit Riemer ,
Bianca Brim  and
Walter Struhal
Edited by
Néstor Gálvez-Jiménez ,
Amos D. Korczyn  and
Ramón Lugo-Sanchez
Néstor Gálvez-Jiménez
Affiliation:
Florida International University
Amos D. Korczyn
Affiliation:
Tel-Aviv University
Ramón Lugo-Sanchez
Affiliation:
Cleveland Clinic
Get access

Summary

Autonomic complications in Parkinsonian syndromes present a considerable cause of reduced quality of life, morbidity, and mortality [1]. Recognition, evaluation, and management are of utmost importance.

The autonomic nervous system is still a field that to many clinicians is obscure or at least its involvement in the clinical course is hard to grasp. This may be based on the considerable widespread knowledge gap and lack of access in electrophysiology evaluation of the autonomic nervous system [2]. However, autonomic syndromes in several autonomic domains are easily evaluable at the bedside, with electrophysiologic autonomic evaluation only necessary in a minority of patients [3]. This chapter will provide a clinical focus on the autonomic cardiovascular, thermoregulatory, urogenital, and gastrointestinal systems.

Type
Chapter
Information
Non-motor Parkinson's Disease , pp. 130 - 144
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Freeman R, , Abuzinadah AR, , Gibbons, C, et al. Orthostatic hypotension. J Am Coll Cardiol 2018; 72(11): 1294–1309.Google Scholar
Novak, P. Quantitative autonomic testing. J Vis Exp 2011; 53: 2502.Google Scholar
Struhal, W, Lahrmann, H, Fanciulli, A, Wenning, GK (eds.). Bedside Approach to Autonomic Disorders: A Clinical Tutor. Springer; 2017.CrossRefGoogle Scholar
Gibbons, CH, Freeman R, . Delayed orthostatic hypotension – a frequent cause of orthostatic intolerance. Neurology 2006; 67(1): 28–32.Google Scholar
Senard, JM, Rai, S, Lapeyre‐Mestre, M, et al. Prevalence of orthostatic hypotension in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1997; 63: 584–589.Google Scholar
Metzler, M, Duerr, S, Granata, R, et al. Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management. J Neurol 2013; 260(9): 2212–2219.CrossRefGoogle ScholarPubMed
Norcliffe-Kaufmann, L, Kaufmann, H, Palma, JA, et al. Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol 2018; 83(3): 522–531.Google Scholar
Michele, B, Moya, A, de Lange, FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J 2018; 39(21): 1883–1948.Google Scholar
Gibbons, CH, Freeman R, . Delayed orthostatic hypotension – a frequent cause of orthostatic intolerance. Neurology 2006; 67(1): 28–32.CrossRefGoogle ScholarPubMed
Fanciulli, A, Strano S, Ndayisaba JP, et al. Detecting nocturnal hypertension in Parkinson’s disease and multiple system atrophy: proposal of a decision-support algorithm. J Neurol 2014; 261(7): 1291–1299.Google Scholar
Fanciulli, A, Jordan, J, Biaggioni, I, et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS). Clin Auton Res 2018; 28: 355–362.Google Scholar
Espay, AJ, Lewitt PA, , Hauser, RA, et al. Neurogenic orthostatic hypotension and supine hypertension in Parkinson’s disease and related synucleinopathies: prioritisation of treatment targets. Lancet Neurol 2016; 15(9): 954–966.Google Scholar
Maule, S, Papotti G, Naso D, et al. Orthostatic hypotension: evaluation and treatment. Cardiovasc Hematol Disord Drug Targets 2007; 7(1): 63–70.CrossRefGoogle ScholarPubMed
van Wamelen DJ, , Leta V, , Podlewska AM, , et al. Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson’s disease. J Neurol 2019; 266: 1736–1742.CrossRefGoogle ScholarPubMed
Swinn L, , Schrag A, , Viswanathan R, , et al. Sweating dysfunction in Parkinson’s disease. Mov Disord 2003; 18: 1459–1463.Google Scholar
Jain S, . Multi-organ autonomic dysfunction in Parkinson disease. Parkinsonism Relat Disord 2011; 17: 77–83.Google Scholar
Coon EA, , Low PA, . Thermoregulation in Parkinson disease. Handb Clin Neurol 2018; 157: 715–725.Google Scholar
Kim JB, , Kim BJ, , Koh SB, , et al. Autonomic dysfunction according to disease progression in Parkinson’s disease. Parkinsonism Relat Disord 2014; 20: 303–307.Google Scholar
Mendoza-Velásquez JJ, , Flores-Vázquez JF, , Barrón-Velázquez E, , et al. Autonomic dysfunction in α-synucleinopathies. Front Neurol 2019; 10: 363.Google Scholar
Sanghera MK, , Ward C, , Stewart RM, , et al. Alleviation of drenching sweats following subthalamic deep brain stimulation in a patient with Parkinson’s disease–a case report. J Neurol Sci 2009; 285: 246–249.CrossRefGoogle Scholar
Bellini G, , Best LA, , Brechany U, , et al. Clinical impact of deep brain stimulation on the autonomic system in patients with Parkinson’s disease. Mov Disord Clin Pract 2020; 7: 373–382.CrossRefGoogle ScholarPubMed
Chen, Z, Li, G, Liu, J. Autonomic dysfunction in Parkinson’s disease: implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis 2020; 134: 104700.Google Scholar
Mulak, A, Bonaz, B. Brain-gut-microbiota axis in Parkinson’s disease. World J Gastroenterol 2015; 21(37): 1060920.CrossRefGoogle ScholarPubMed
Kim, JS, Sung, HY. Gastrointestinal autonomic dysfunction in patients with Parkinson’s disease. J Mov Disord 2015; 8(2): 76–82.CrossRefGoogle Scholar
Palma, JA, Kaufmann, H. Autonomic disorders predicting Parkinson’s disease. Parkinsonism Relat Disord 2014; 20(S1): S94–S98.CrossRefGoogle Scholar
Csoti, I, Jost, WH, Reichmann, H. Parkinson’s disease between internal medicine and neurology. J Neural Transm 2016; 123(1): 3–17.CrossRefGoogle Scholar
Ziemssen, T, Schmidt, C, Herting, B, Reichmann, H. Autonome Dysfunktion beim idiopathischen Parkinson-Syndrom und der Multisystematrophie [Autonomic Dysfunction in Parkinson’s Disease and Multiple System Atrophy]. Georg Thieme Verlag; 2006.Google Scholar
Palma, JA, Kaufmann, H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord 2018; 33(3): 372–390.Google Scholar
Trapl, M, Enderle, P, Nowotny, M, et al. The Gugging Swallowing Screen. Stroke 2007; 38: 2948.CrossRefGoogle Scholar
Fasano, A, Bove F, Gabrielli M, et al. The role of small intestinal bacterial overgrowth in Parkinson’s disease. Mov Disord 2013; 28(9): 1241–1249.CrossRefGoogle Scholar
Wakabayashi, K, Takahashi, H. Neuropathology of autonomic nervous system in Parkinson’s disease. Eur Neurol 1997; 38(Suppl 2): 2–7.Google Scholar
Vurture, G, Peyronnet, B, Palma, JA, et al. Urodynamic mechanisms underlying overactive bladder symptoms in patients with Parkinson disease. Int Neurourol J 2019; 23: 211–218.Google Scholar
Sakakibara, R, Uchiyama, T, Yamanishi, T, et al. Genitourinary dysfunction in Parkinson’s disease. Mov Disord 2010; 25: 2–12.CrossRefGoogle ScholarPubMed
Barone, P, Antonini, A, Colosimo, C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 2009; 24: 1641–1649.Google Scholar
Batla, A, Phé, V, De Min, L, et al. Nocturia in Parkinson’s Disease: why does it occur and how to manage? Mov Disord Clin Pract 2016; 3: 443–451.Google Scholar
Campos-Sousa, RN, Quagliato, E, da Silva, BB, et al. Urinary symptoms in Parkinson’s disease: prevalence and associated factors. Arq Neuropsiquiatr 2003; 61(2B): 359–363.CrossRefGoogle ScholarPubMed
Kapoor, S, Bourdoumis, A, Mambu, L, et al. Effective management of lower urinary tract dysfunction in idiopathic Parkinson’s disease. Int J Urol 2013; 20: 79–84.CrossRefGoogle ScholarPubMed
Chen, Z, Li, G, Liu, J. Autonomic dysfunction in Parkinson’s disease: implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis 2020; 134: 104700.Google Scholar
Pavy-Le Traon, A, Cotterill, N, Amarenco, G, et al. Clinical rating scales for urinary symptoms in Parkinson disease: critique and recommendations. Mov Disord Clin Pract 2018; 5 :479–491.CrossRefGoogle ScholarPubMed
Palma, JA, Kaufmann, H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord 2018; 33: 372–390.CrossRefGoogle ScholarPubMed
Winge, K, Werdelin, LM, Nielsen, KK, et al. Effects of dopaminergic treatment on bladder function in Parkinson’s disease. Neurourol Urodyn 2004; 23: 689–696.CrossRefGoogle ScholarPubMed
Seppi, K, Chaudhuri, KR, Coelho, M, et al. Update on treatments for nonmotor symptoms of Parkinson’s disease: an evidence-based medicine review. Mov Disord 2019; 34: 180–198.CrossRefGoogle ScholarPubMed
Keam, SJ. Vibegron: first global approval. Drugs 2018; 78: 1835–1839.Google Scholar
Basiago, A, Binder, DK. Effects of deep brain stimulation on autonomic function. Brain Sci 2016; 6: 33.Google Scholar
Bronner, G, Royter, V, Korczyn, AD, et al. Sexual dysfunction in Parkinson’s disease. J Sex Marital Ther 2004; 30: 95–105.CrossRefGoogle ScholarPubMed
Pfeiffer, RF. Management of autonomic dysfunction in Parkinson’s disease. Semin Neurol 2017; 37: 176–185.Google ScholarPubMed
Malek, N, Lawton, MA, Grosset, KA, et al. Autonomic dysfunction in early Parkinson’s disease: results from the United Kingdom Tracking Parkinson’s Study. Mov Disord Clin Pract 2016; 4: 509–516.Google Scholar
Gao, X, Chen, H, Schwarzschild, MA, et al. Erectile function and risk of Parkinson’s disease. Am J Epidemiol 2007; 166: 1446–1450.CrossRefGoogle ScholarPubMed
Bhattacharyya, KB, Rosa-Grilo, M. Sexual dysfunctions in Parkinson’s disease: an underrated problem in a much discussed disorder. Int Rev Neurobiol 2017; 134: 859–876.Google Scholar
Hussain, IF, Brady, CM, Swinn, MJ, et al. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson’s disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 2001; 71: 371–374.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×